Clinical Trial Update: A Study Between Dapagliflozin and Empagliflozin Effect on NAFLD in Patients With Type 2 Diabetes. [Phase 4]

View source ↗

Summary

A Phase 4 study comparing the effects of dapagliflozin versus empagliflozin on nonalcoholic fatty liver disease in patients with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (Farxiga) (dapagliflozin)
• Empagliflozin (Jardiance) (empagliflozin)

Snippet

Sponsor: Beni-Suef University | Conditions: NAFLD (Nonalcoholic Fatty Liver Disease) | Phase 4 | Status: COMPLETED